| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 5.456 | 8.227 | 9.002 | 8.079 | 0 | 12.129 | 25.534 | 25.450 | 22.439 |
| Total Income - EUR | - | 5.456 | 8.227 | 9.002 | 8.079 | 0 | 12.129 | 25.534 | 25.450 | 22.439 |
| Total Expenses - EUR | - | 150 | 1.852 | 2.245 | 777 | 0 | 3.960 | 7.868 | 13.241 | 17.395 |
| Gross Profit/Loss - EUR | - | 5.306 | 6.375 | 6.757 | 7.302 | 0 | 8.169 | 17.666 | 12.208 | 5.044 |
| Net Profit/Loss - EUR | - | 5.142 | 6.128 | 6.487 | 7.059 | 0 | 7.805 | 16.900 | 11.954 | 4.371 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Urolifemed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 16 | 16 | 0 | 0 | 0 | 0 | 13.351 | 11.431 | 10.504 |
| Current Assets | - | 5.439 | 11.314 | 17.584 | 13.154 | 12.903 | 8.965 | 19.943 | 10.954 | 14.697 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 844 | 0 | 1.347 |
| Receivables | - | 746 | 0 | 0 | 2 | 0 | 0 | 0 | 340 | 0 |
| Cash | - | 4.693 | 11.314 | 17.584 | 13.152 | 12.903 | 8.965 | 19.100 | 10.614 | 13.350 |
| Shareholders Funds | - | 5.186 | 11.226 | 6.530 | 13.138 | 12.889 | 8.279 | 21.150 | 11.996 | 12.321 |
| Social Capital | - | 45 | 44 | 43 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | - | 268 | 103 | 11.054 | 16 | 13 | 686 | 12.144 | 10.389 | 12.879 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Urolifemed Srl